Disease control in advanced Hodgkin lymphoma

Interim results of RELEVANCE trial in follicular lymphoma

Mapping 3D genome dynamics in B cells

Novel fusion proteins to target PD-L1 in HPV associated cancers

Phase I study results of M7824 for patients with HPV associated cancers

Early results from a 3rd gen EGFR-TKI in advanced NSCLC

Zoptarelin no better than doxarubicin for second-line advanced endometrial cancer

First-in-human phase 1 study of TAK-931 for solid tumours

Matching mutations in tumours to precision medicine improves survival

Development of blood tests for early lung cancer

Editor’s Choice for May 2018

Incorporating biomarkers into clinical trial design